Literature DB >> 9358030

A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor.

A R Kianmanesh1, H Perrin, Y Panis, M Fabre, H J Nagy, D Houssin, D Klatzmann.   

Abstract

Antitumor gene therapy using herpes simplex type 1 thymidine kinase (TKh) and ganciclovir (GCV) treatment has revealed an important intratumoral bystander effect. A whole tumor can be eliminated when only a fraction of its tumor cells express TKh. We now report that the bystander effect not only acts within a tumor, but also between distant tumors. One TKh+ tumor was generated simultaneously with one or multiple TKh- tumors in different rat liver lobes such that there was no contact between the resulting tumors. Both the TKh+ and the TKh- tumors regressed after GCV treatment and showed infiltration with macrophages and T lymphocytes. This distant bystander effect, which is likely immune mediated, should be of major importance for gene therapy of disseminated tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358030     DOI: 10.1089/hum.1997.8.15-1807

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  14 in total

1.  Targeted gene therapy of the HSV-TK/hIL-12 fusion gene controlled by the hSLPI gene promoter of human non-small cell lung cancer in vitro.

Authors:  Shuhong Hao; Xiaoyuan Du; Yang Song; Ming Ren; Qiwei Yang; Ao Wang; Qingyu Wang; Haiyue Zhao; Zhenwu Du; Guizhen Zhang
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

Review 2.  [Molecular therapy in gastroenterology and hepatology].

Authors:  J Wedemeyer; N P Malek; M P Manns; M J Bahr
Journal:  Internist (Berl)       Date:  2005-08       Impact factor: 0.743

Review 3.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

Review 4.  Gene-directed enzyme prodrug therapy.

Authors:  Jin Zhang; Vijay Kale; Mingnan Chen
Journal:  AAPS J       Date:  2014-10-23       Impact factor: 4.009

5.  Enhanced central memory cluster of differentiation 8+ and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy.

Authors:  Makoto Kubo; Takefumi Satoh; Ken-Ichi Tabata; Hideyasu Tsumura; Masatsugu Iwamura; Shiro Baba; Timothy C Thompson; Fumiya Obata
Journal:  Mol Clin Oncol       Date:  2015-02-26

Review 6.  Prospects for vaccination in prostate cancer.

Authors:  M J Perry; D Hroulda; A G Dalgleish
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

7.  Subcutaneous or intrahepatic injection of suicide gene modified tumour cells induces a systemic antitumour response in a metastatic model of colon carcinoma in rats.

Authors:  V Pierrefite-Carle; P Baqué; A Gavelli; N Brossette; D Benchimol; A Bourgeon; M C Saint Paul; P Staccini; B Rossi
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

8.  TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancer.

Authors:  Shan-Yu Guo; Qin-Long Gu; Zheng-Gang Zhu; He-Qun Hong; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Increased anti-tumor effect by a combination of HSV thymidine kinase suicide gene therapy and interferon-gamma/GM-CSF cytokine gene therapy in CT26 tumor model.

Authors:  Sung Hyun Yang; Tae Keun Oh; Seung Taik Kim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

10.  Enforced effect of tk-MCP-1 fusion gene in ovarian cancer.

Authors:  Shuhui Hong; Ping Zhang; Hui Zhang; Lin Jia; Xun Qu; Qifeng Yang; Fengnian Rong; Beihua Kong
Journal:  J Exp Clin Cancer Res       Date:  2012-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.